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invasive fungal infection; living donor liver transplantation; β -D glucan; risk factor; complication © 2006 Tohoku University Medical Press Fungal infection is a potentially fatal complication in patients subjected to liver transplantation. The incidence of fungal infection in liver transplantation is higher than in transplantation of other solid organs, ranging from 4 to 42% with a mortality of 25-69% (Patel et al. 1996; Singh et al. 1997 Singh et al. , 2002 Rabkin et al. 2000; Paya 2001 ).
Many reports have been published about risk factors for invasive fungal infection in recipients of deceased donor liver grafts (Gladdy et al. 1999; Fortun et al. 2002) ; on the other hand, there have been no reports about the risk factors for living donor liver transplantation (LDLT). Most LDLTs are elective surgery, thus it is possible to treat pre-existing infections and prepare the patient by administering prophylactic agents. However, in LDLT the graft is smaller than that recovered from a deceased donor, and it involves technical difficulties such as the small diameter of vessels and biliary ducts. Therefore, it needs to have special consideration for the invasive fungal infection in LDLT (Suzuki et al. 2000) . So it is important to know the risk factors in LDLT for the early management.
In the clinical field, it is very difficult to diagnose an invasive fungal infection in the early stage, because the pathogens cannot be detected until the infection has become quite severe (Aikawa et al. 2002) . Besides, there are no significantly superior chemical makers for the diagnosis of invasive fungal infection. Therefore, there are no global standardized criteria in this regard (Avery 2001) . In Japan serum β -D glucan is used for the diagnosis of fungal infection. Obayashi et al. (1995) reported that serum β -D glucan was a highly sensitive and specific test for invasive deep mycosis and fungal febrile episodes, and would substantially benefit immunocompromised patients. In the present study we investigated the specificity and sensitivity of β -D glucan for the detection of invasive fungal infection in LDLT recipients. This test, however, provides no information on cryptococcosis, because C neoformans produces less β -D glucan than do candida and asperillus (Obayashi et al. 1995) . But we experienced its usefulness in case of Pneumocystis carinii pneumonia whose clinical symptoms are closely correlated with the level of β -D glucan.
In this study we review our experience with fungal infections in LDLT recipients and report the risk factors for invasive fungal infection. We also discuss the usefulness of the β -D glucan in the diagnosis and therapeutical evaluation of invasive fungal infection in LDLT recipients.
PATIENTS AND METHODS

Characteristics of the patients
From July 1991 to November 2005, 96 living related liver transplantations were performed in pediatric and adult patients with end-stage liver disease in the Division of Advanced Surgical Science and Technology, Graduate School of Medicine, Tohoku University. This program was approved by the ethics committees in our hospital and the patients were given informed consent about the LDLT. Donors were selected among parents, brothers or sisters and spouses on the basis of liver function tests, serological markers of hepatitis, ABO blood group, graft/ recipient size matching, lymphocyte cross-matching and human leukocyte (lymphocyte) antigen typing. All the recipients were trasplanted the right lobe, left lobe or the left lateral segment of the liver. The primary diseases of the recipients were biliary atresia in 54, primary biliary cirrhosis (PBC) in 12, hepatocellular carcinoma in 6, cryptogenic liver cirrhosis in 4, metabolic disorders in 4, and other diseases in 16. These 96 recipients were 57 females and 39 males. The mean age was 18 years 8 month, ranging from 5 months to 63 years, and the mean weight was 31.2 kg, ranging from 5.3 kg to 89.0 kg at the time of transplantation.
Anti-infection therapy and immunosuppressive therapy
Several specimens, including pharyngeal swabs, nasal swabs, urine and feces were cultured before LDLT and if methicillin-resistant staphylococcus aureus (MRSA) or fungus were isolated, they were treated by vancomycin, mupirocin calcium and fluconazole. Routine preoperative bowel preparation was performed orally by fluconazole (3 mg/kg/day) and kanamycin (50 mg/kg/day) for 3 days before surgery and gargle by amphotericin B. For the children above 2 years old who had been performed splenectomy or had a plan of splenectomy at the time of transplantation, they had vaccination for Streptococcus pneumoniae and Hemophilus influenzae before transplantation. Fluconazole (5 mg/kg/ day) or micafungin (50 mg/day) were given intravenously for fungal prophylaxis for the first 1 week after operation. From the second week after transplantation fluconazole was given orally at the dose of 3 mg/kg/day for another one or two weeks. Trimethoprimsulfamethoxazole was given routinely for Pneumocystis carinii. Febrile episode were treated empirically with broad-spectrum antibioticus until culture results were known. Thereafter, bacterial infections were treated with antibiotics based on specific sensitivity patterns. Recipients with suspected fungal infection underwent a chest or abdominal computed tomography (CT) scan, when appropriate, and fundoscopy for Candida endophthalmitis, and suspected sites of infection were cultured. Fungal infections were identified in some ways, they were treated with an initial dose of fluconazole (3-6 mg/kg/day), amphotericin B (0.25 mg/kg/day), micafungin (100-150 mg/day) or flucytosine (100 mg/day). Routine surveillance cultures after transplantation were obtained from pharyngeal swabs, nasal swabs, urine, central venous lines, abdominal drains, nasogasrtic tubes, endotracheal tubes and stool. Venous and urinary catheters were routinely changed when colonization of an indwelling tube was suspected. Serum level of Candida, Aspergillus and Cryptococcus antigens were also measured for the diagnosis. The culture medium used was fungus specific. Candida antigen was detected by latex agglutination and the positive value was more than two times higher compared to control. Asperguillus antigen was detected by latex agglutination and this is qualitative analysis. Cryptococcus antigen was detected by latex agglutination and the positive value was more than eight times higher compared to control. β -D glucan was determined by test kits (Wako, Inc., Tokyo), and the cut-off value was 11 pg/ml. The timing of sampling for these parameters was twice before transplantation and twice per week for one or two months after transplantation. The value was the maximal one.
The immunosuppressive regimen consisted of cyclosporine (CsA), tacrolimus (TAC), azathioprine (AZ), mycophenolate mofetil (MMF) and methylprednisolone (MP).
Definitions of invasive fungal infection
Fungal colonization was defined as the presence of a fungus in one or more surveillance superficial cultures in the absence of any clinical symptoms or signs of infection. Invasive fungal infections were divided into definite and probable infections according to the following criteria : definite invasive fungal infection was diagnosed by one of these criteria as follows: 1) presence of fungus in the blood, cerebrospinal fluid, ascites and biopsy specimens; 2) ophthalmologic evidence; 3) isolation of fungus from bronchoalveolar lavage with radiological evidence of pneumonitis. Probable invasive fungal infection was defined as isolation of a fungus from one superficial site and more than 11 pg/ml serum level of β -D glucan or one of these two criteria together with febrile symptom above 38°C which was not responded by antibiotics for more than one week or radiological evidence of pneumonitis or esophagitis.
Clinical data analysis
Clinical data were analyzed to determine the risk factors that might contribute to the fungal infections. Preoperative factors such as gender, age at transplantation, body weight, serum total bilirubin and creatinine levels, number of pre-transplanat abdominal surgery, pre-transplanat plasmapheresis and pre-transplant fungal colonization were compiled. Intraoperative variables included duration of operation, blood loss, graft vs recipient ratio and the type of biliary reconstruction. Postoperative variables were collected until present time. This included the number of laparotomies and plasma exchange, total number of days in intensive care unit (ICU), total number of days intubated, vascular and biliary complications, number of viral and methicillinresistant staphylococcus aureus (MRSA) infections, episodes of biopsy proven rejections, graft-recipient weight ratio. Respiratory failure was defined as requiring intubation for more than 2 weeks or re-intubation, renal failure was defined as continuous hemodiafiltration (CHDF), continuous hemofiltration (CHF) or hemodialysis (HD) was initiated. Statistical analyses were performed using Stat View 4.5 (Abacus Concepts, Inc., Berkeley, CA, USA). Univariate statistical analysis for invasive fungal infection vs control group was performed by means of the Fisher's exact test for categorical variables and MannWhitney's U-test for continuous variables. P value less than 0.05 was considered statistically significant. The factors identified on univariate analysis to be associated with p value less than 0.20 were then entered into a stepwise logistic regression analysis to identify independent risk factors for invasive fungal infection.
RESULTS
During the study period, mycoses were detected in 48 patients (50.0%) before LDLT, in 63 (65.6%) after LDLT, and in 38 (39.6%) patients during both periods (Table 1) . Before LDLT C. albicans was isolated from 72.9% of the recipients followed by C. glabrata (18.8%), and others (8.3%). After LDLT, C. albicans was isolated from 71.4% of the recipients followed by C. glabrata (31.7%), yeast like fungus (15.9%), Candida spp (12.7%), C. guilliermondii (7.9%) and C. tropicalis (7.9%). The intestines and pharynx were the most frequent colonized sites followed by urine and stomach. Forty-eight recipients who had fungal colonization before LDLT had no symptoms of infection. Sera from 8 patients were positive for Candida antigens b e f o r e L D LT a n d f r o m 1 8 a f t e r L D LT. Aspergillus antigen was not detected in serum from any patient in our institution and Aspergillus spp was isolated from two recipients but it was not responsible for fungal infection. There was no patient with pneumonia or meningitis caused by Aspergillus species. Cryptococcus luteolus was isolated once before LDLT and serum Cryptococcus antigen was detected in one recipient after LDLT. None of the patients had severe infection caused by Cryptococcus species.
We experienced 2 definite and 6 probable cases of invasive fungal infections ( Table 2) . Most of the invasive fungal infections occurred within 2 months after LDLT. Seven recipients were diagnosed as having pneumonia by chest X-ray or CT scan and one recipient was diagnosed sepsis based on the results of an arterial blood culture. C. albicans was isolated from sputa of 4 out of eight recipients with a body temperature of 38°C or more and radiological evidence of pneumonia. Five out of eight recipients with invasive fungal infections died because of graft failure or multiple organ failure. No fungus was isolated from two of 6 patients with probable fungal infections who had high serum levels of β -D glucan (86, 38 pg/ml), a body temperature of 38°C or more and radiological evidence of pneumonia. Two recipients who showed an improvement of their fungal pneumonia were treated with fluconazole and antibiotics. One recipient who was diagnosed as having Pneumocystis carinii pneumonia had a quite high serum level of β -D glucan (169 pg/ml) and his clinical symptoms correlated with the level of β -D glucan. He was found to be positive for Pneumocystis carinii in his sputa from bronchoalveolar lavage (BAL) by polymerase chain reaction (PCR) and X-ray findings revealed pneumonia; thus, he was treated with trimethoprim-sulfamethoxazole. Twenty-six factors, including 7 pretransplantation, 4 intraoperative, and 15 posttransplantation variables, were examined by univariate analysis to determine the risk factors that predispose to invasive fungal infection (Table 3) . We did not show β -D glucan as a factor, because it was not measured in the first 21 patients. But there was a significant difference between recipients with invasive fungal infections and those with noninvasive fungal infections ( p = 0.001). The statistically significant factors were the number of posttransplant episodes of acute blood purification (plasma exchange with or without CHDF) ( p = 0.031), hepatic vein complications ( p = 0.014), renal failure ( p = 0.004) and respiratory failure ( p = 0.005), etc. Multivariate analysis showed an independent association of the development of invasive fungal infection with hepatic vein complications (OR, 26.1 [95% CI, 
DISCUSSION
Invasive fungal infection is one of the fatal complications and influences the survival of LDLT recipients. In this report we investigated the risk factors for invasive fungal infection and the usefulness of β -D glucan as an indicator of this type of infection in LDLT recipients. In our institution Candida spp. was the species most frequently isolated pre-and post-transplantation, and among them C. albicans accounted for over 70% of the isolates. This result derived from the high level of gastrointestinal colonization with Candida spp., manipulation of the gastrointestinal tract during surgery with increased translocation across the gut mucosal barrier, and impaired hepatic reticuloendothelial function (Matsumoto et al. 2004) , as well as prolonged use of an indwelling catheter which promotes fungal colonization by providing a vascular portal of entry.
In deceased donor liver transplantation (DDLT) Candida spp. constitute the most frequent cause of invasive fungal infection followed by Aspergillus spp., and the same tendency is observed in LDLT. Among Candida spp., C. albicans was the most predominant followed by C. glabrata, C. tropicalis, C. parapsilosis, C. krusei (Gladdy et al. 1999; Kawagishi et al. 2004; Takakura et al. 2004) . Candida overgrowth in the lumen of the gastrointestinal tract is secondary to changes in the bacterial flora. It has been clearly established that the presence of anaerobic bacteria in the gut conveys a protective effect as they neutralize the overgrowth of Candida (van der Waaij 1982) . This has been the basis for the use of selective bowel decontamination regimens, the main goal of which is to maintain a healthy anaerobic flora (Arnow et al. 1996; van der Waaij et al. 1982; Wiesner et al. 1988) . Some selective bowel decontamination regimens have included oral amphotericin preparations to further enhance the elimination of Candida from the bowel. The clinical effectiveness of this technique in reducing systemic Candida infection, however, remains unknown. In our experience drug resistant C. glabrata meight be increased in the invasive fungal infection through the intensive use of prophylactic agents with our protocol.
In our series there were 8 recipients with invasive fungal infections, including 6 probable cases, and of them 5 died. Other authors also reported that the development of invasive fungal infection after liver transplantation was associated with a high mortality rate of up to 80% due to the difficulty in making an early diagnosis of the disease (Nieto-Rodriguez et al. 1996; Gladdy et al. 1999; Fortun et al. 2002) . Particularly, invasive aspergillosis was quite fatal (Fortun et al. 2002) . Diagnosis of invasive fungal infection by conventional superficial cultures and fungal isolation from tissues, bronchoalveolar lavage or cerebrospinal fluid from patients with clinical symptoms has some limitations. But recently, diagnostic testing in the field of medical mycology has improved allowing an earlier diagnosis of infection and the possibility to monitor the response to therapy in a noninvasive manner. An assay that measures 1-3 β -D glucan, a panfungal cell wall component, as a potentially promising indicator of invasive fungal infection has been developed (Obayashi et al. 1995 (Obayashi et al. , 2004 Ostrosky-Zeichner et al. 2005; Pazos et al. 2005) . Although some false positives may result from hemodialysis using certain cellulose membranes, gauzes and albumin products (Nakao et al. 1997; Sakai et al. 2000; Kato et al. 2001) , we think that this method is useful for the early diagnosis of invasive fungal infection. In our experience the specificity of β -D glucan was 100%. Besides, it was very useful to monitor the results of therapy for Pneumocystis carinii pneumonia. However it should also be recognized that β -D glucan is not expected to detect cryptoccocosis due to the low content of 1-3-β -D-glucan in the cell wall of Cryptoccocus species (Miyazaki et al. 1995) .
The risk factors for invasive fungal infection in liver transplantation have been reported by many authors (Gladdy et al. 1999; Avery et al. 2001; Paya 2001; Fortun et al. 2002; Singh et al. 2002; Takakura et al. 2004) . But these were identified mainly from their experiences with DDLT. Therefore, we think that risk factors in LDLT recipients should be discussed. In Japan, we have experienced more than 3,000 cases of LDLT so far (Japan Liver Transplantation Society, personal communication), fungal infection is one of the fatal complications (Suzuki et al. 2000) . In DDLT, bile leakage, hepatic artery thrombosis, preoperative steroids, blood transfusion during the operation, respiratory failure, hyperglycemia, retransplantation, and renal failure were reported as independent risk factors (Nieto-Rodriguez et al. 1996; Gladdy et al 1999; Fortun et al. 2002) . Some other series identified thrombocytopenia, bacterial and viral infections and pre-transplant fungal colonization as risk factors (Avery et al. 2001; Verma et al. 2005 ). In our series, there were no pre-nor intra-operative variables identified as risk factors (except body weight and graft/ recipient ratio) by univariate analysis. This may derive from the fact that LDLT is usually set up under the condition of elective surgery and prophylaxis for fungal infection is provided before transplantation, contrary to what happens in case of DDLT. Moreover, donor-transmitted infection does not happen in LDLT. Hepatic vein complications and respiratory failure were identified as risk factors by multivariate analysis in our series, these results were comparable to the reported risk factors in DDLT. But we consider that hepatic vein complication is a characteristic risk factor for LDLT, particularly when the left lobe is used as the graft. Because in such cases once hepatic vein complications occur, liver damage becomes more serious unless proper therapy is provided. This kind of serious liver damage is an important risk for the development of invasive fungal infection.
In conclusion, invasive fungal infection is an important cause of death after LDLT. We identified two factors associated with the development of invasive fungal infection : hepatic vein complications and respiratory failure. For the prevention and treatment of invasive fungal infection in LDLT, it is important to notify these risk factors, and we need more studies on early non-invasive quantitative markers like β -D glucan.
